Table 2: Number and percentage of patients with criteria fulfilled in second phase
Criteria Standard   Yes   No   Unknown Not indicated
1. Register 100%   352 (100%)   0 (0%)   / /

2.

BP measured at least in 2 occasions prior to commencement of drug therapy 90%   96 (27.3%)   16 (4.6%)   223 (63.9%) /
  % of cases if unknown cases excluded       87.3%     12.7%      

3.

Symptoms and signs of target organ damage assessed: 90%                  
  a. retinopathy     38 (10.8%)   314 (89.2%)   / /
  b. left ventricular hypertrophy     89 (25.3%)   263 (74.7%)   / /
  c. angina     217 (61.6%)   135 (38.4%)   / /
  d. stroke     59 (16.8%)   293 (83.2%)   / /
  e. heart failure     234 (66.5%)   118 (33.5%)   / /
  f. peripheral vascular disease     42 (11.9%)   308 (88.1%)   / /
  g. renal disease     229 (65.1%)   123 (34.9%)   / /
4. Risk factors for cardiovascular and cerebrovascular disease assessed 90%                  
  a. smoking habit     352 (100%)   0 (0%)   / /
  b. body mass index     351 (99.7%)   1 (0.3%)   / /
  c. diabetes mellitus     342 (97.2%)   10 (2.8%)   / /
  d. serum cholesterol     332 (94.3%)   20 (5.7%)   / /
  e. excessive alcohol intake     352 (100%)     0 (0%)   / /
  f. physical inactivity     340 (96.6%)   12 (3.4%)   / /
  g. family history of coronary artery disease     351 (99.7%)   1 (0.3%)   / /

5.

 Pre-treatment BP > 140/90 90%   119 (33.8%)   1 (0.3%)   232 (65.9%) /
  % of cases if unknown cases excluded       99.2%     0.8%      
6. Patient reviewed at least every 6 months 90%   344 (97.7%)   8 (2.3%)   / /
7. a. Blood pressure <140/90 70%   233 (66.2%)   119 (33.8%)   / /

 

 b. Blood pressure <130/80 for patients with diabetes or renal disease     26 (32.5%)   54 (67.5%)   / /

8.

Patient referred for specialist advice 90%   6 (1.7%)   1 (0.3%)   / 345 (98%)
  % if cases not indicated excluded       85.7%     14.3%      
9. Side effects of drugs assessed annually 80%   271 (77%)   81 (23%)   / /
10. Diet advice given annually 80%   319 (90.6%)   33 (9.4%)   / /